These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7521339)

  • 1. Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus.
    Hilding A; Brismar K; Thorén M; Hall K
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1142-7. PubMed ID: 7521339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    Hilding A; Brismar K; Degerblad M; Thorén M; Hall K
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.
    Brismar K; Fernqvist-Forbes E; Wahren J; Hall K
    J Clin Endocrinol Metab; 1994 Sep; 79(3):872-8. PubMed ID: 7521354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action.
    Ezzat S; Ren SG; Braunstein GD; Melmed S
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1459-63. PubMed ID: 1281485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT; Barrios V; Pozo J; Argente J
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
    Gibson JM; Westwood M; Crosby SR; Gordon C; Holly JM; Fraser W; Anderson C; White A; Young RJ
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency.
    Bang P; Brandt J; Degerblad M; Enberg G; Kaijser L; Thorén M; Hall K
    Eur J Clin Invest; 1990 Jun; 20(3):285-92. PubMed ID: 1695151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth.
    McIntyre HD; Serek R; Crane DI; Veveris-Lowe T; Parry A; Johnson S; Leung KC; Ho KK; Bougoussa M; Hennen G; Igout A; Chan FY; Cowley D; Cotterill A; Barnard R
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1143-50. PubMed ID: 10720053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
    Bach MA; Chin E; Bondy CA
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
    Young SC; Underwood LE; Celniker A; Clemmons DR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J; Keliner K; Zilkens T; Schmidt-Gayk H; Selisko T; Scholz GH
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.